A resource to empirically establish drug exposure records directly from untargeted metabolomics data

. 2025 Dec 09 ; 16 (1) : 10600. [epub] 20251209

Jazyk angličtina Země Velká Británie, Anglie Médium electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid41366203

Grantová podpora
P50 HD106463 NICHD NIH HHS - United States
ZIC ES103363 Intramural NIH HHS - United States
K99 ES037746 NIEHS NIH HHS - United States
U19 AG063744 NIA NIH HHS - United States
R01 DK136117 NIDDK NIH HHS - United States
P30 MH062512 NIMH NIH HHS - United States
R37 AI126277 NIAID NIH HHS - United States
F32 AT011475 NCCIH NIH HHS - United States
U24 DK133658 NIDDK NIH HHS - United States

Odkazy

PubMed 41366203
PubMed Central PMC12689629
DOI 10.1038/s41467-025-65993-5
PII: 10.1038/s41467-025-65993-5
Knihovny.cz E-zdroje

Despite extensive efforts, extracting medication exposure information from clinical records remains challenging. To complement this approach, here we show the Global Natural Product Social Molecular Networking (GNPS) Drug Library, a tandem mass spectrometry (MS/MS) based resource designed for drug screening with untargeted metabolomics. This resource integrates MS/MS references of drugs and their metabolites/analogs with standardized vocabularies on their exposure sources, pharmacologic classes, therapeutic indications, and mechanisms of action. It enables direct analysis of drug exposure and metabolism from untargeted metabolomics data, supporting flexible summarization at multiple ontology levels to align with different research goals. We demonstrate its application by stratifying participants in a human immunodeficiency virus (HIV) cohort based on detected drug exposures. We uncover drug-associated alterations in microbiota-derived N-acyl lipids that are not captured when stratifying by self-reported medication use. Overall, GNPS Drug Library provides a scalable resource for empirical drug screening in clinical, nutritional, environmental, and other research disciplines, facilitating insights into the ecological and health consequences of drug exposures. While not intended for immediate clinical decision-making, it supports data-driven exploration of drug exposures where traditional records are limited or unreliable.

Biological Sciences Division Pacific Northwest National Laboratory Richland WA USA

Catalan Institute for Water Research Girona Spain

Center for Microbiome Innovation University of California San Diego La Jolla CA USA

Chiba University UC San Diego Center for Mucosal Immunology Allergy and Vaccines La Jolla CA USA

Collaborative Mass Spectrometry Innovation Center University of California San Diego La Jolla CA USA

Department of Bioengineering University of California San Diego La Jolla California USA

Department of Biological Sciences University of Alberta Edmonton AB Canada

Department of Computer Science and Engineering University of California Riverside Riverside CA USA

Department of Computer Science and Engineering University of California San Diego La Jolla CA USA

Department of Computer Science University of Antwerp Antwerp Belgium

Department of Computing Science University of Alberta Edmonton AB Canada

Department of Environmental Chemistry Institute of Environmental Assessment and Water Research Barcelona Spain

Department of Medicinal Chemistry University of Washington Seattle WA USA

Department of Medicine Duke University Durham NC USA

Department of Medicine University of California San Diego La Jolla CA USA

Department of Neurosciences University of California San Diego La Jolla CA USA

Department of Obstetrics Gynecology and Reproductive Sciences University of California San Diego La Jolla CA USA

Department of Pediatrics University of California San Diego La Jolla CA USA

Department of Pharmaceutical Sciences University of Vienna Vienna Austria

Department of Pharmacy University of Oslo Oslo Norway

Department of Plant Pathology University of Wisconsin Madison Madison WI USA

Department of Psychiatry and Behavioral Sciences Duke University Durham NC USA

Department of Psychiatry University of California San Diego La Jolla CA USA

Duke Institute of Brain Sciences Duke University Durham NC USA

Faculty of Chemistry Federal University of Pará Belém PA Brazil

Halıcıoğlu Data Science Institute University of California San Diego La Jolla CA USA

HIV Neurobehavioral Research Program University of California San Diego La Jolla CA USA

Immunity Inflammation and Disease Laboratory Division of Intramural Research National Institute of Environmental Health Sciences National Institutes of Health Research Triangle Park Bethesda NC USA

Institute of Biomedicine and Turku Bioscience Centre University of Turku and Åbo Akademi University Tykistönkatu 6A 20520 Turku Finland

Institute of Microbiology Eidgenössische Technische Hochschule Zürich Zürich Switzerland

Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences Prague Czechia

Program in Materials Science and Engineering University of California San Diego La Jolla CA USA

Scripps Institution of Oceanography University of California San Diego La Jolla CA USA

Shu Chien Gene Lay Department of Bioengineering University of California San Diego La Jolla CA USA

Skaggs School of Pharmacy and Pharmaceutical Sciences University of California San Diego La Jolla CA USA

Před aktualizací

PubMed

Zobrazit více v PubMed

Vermeulen, R., Schymanski, E. L., Barabási, A.-L. & Miller, G. W. The exposome and health: Where chemistry meets biology. PubMed DOI PMC

National Center for Health Statistics. Health, United States, 2019. Hyattsville, MD (2021). PubMed

Rappaport, S. M., Barupal, D. K., Wishart, D., Vineis, P. & Scalbert, A. The blood exposome and its role in discovering causes of disease. PubMed DOI PMC

de la Cuesta-Zuluaga, J., Boldt, L. & Maier, L. Response, resistance, and recovery of gut bacteria to human-targeted drug exposure. PubMed DOI

Verdegaal, A. A. & Goodman, A. L. Integrating the gut microbiome and pharmacology. PubMed DOI PMC

Vila, A. V. et al. Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. PubMed DOI PMC

Maier, L. et al. Extensive impact of non-antibiotic drugs on human gut bacteria. PubMed DOI PMC

Sinnott, S.-J., Polinski, J. M., Byrne, S. & Gagne, J. J. Measuring drug exposure: concordance between defined daily dose and days’ supply depended on drug class. PubMed DOI PMC

Althubaiti, A. Information bias in health research: definition, pitfalls, and adjustment methods. PubMed DOI PMC

Gong, Y. et al. Over-the-counter antibiotic sales in community and online pharmacies, China. PubMed DOI PMC

Mackey, T. K. et al. Multifactor quality and safety analysis of antimicrobial drugs sold by online pharmacies that do not require a prescription: Multiphase observational, content analysis, and product evaluation study. PubMed DOI PMC

Essigmann, H. T. et al. Epidemiology of antibiotic use and drivers of cross-border procurement in a Mexican American border community. PubMed PMC

Walmsley, B. et al. The PrEP You Want: A web-based survey of online cross-border shopping for HIV prophylaxis medications. PubMed DOI PMC

Vauquelin, G. & Charlton, S. J. Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action. PubMed DOI PMC

Copeland, R. A. The drug–target residence time model: a 10-year retrospective. PubMed DOI

Wishart, D. S. et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. PubMed DOI PMC

Wishart, D. S. et al. DrugBank 5.0: a major update to the DrugBank database for 2018. PubMed DOI PMC

Ursu, O. et al. DrugCentral: online drug compendium. PubMed DOI PMC

DailyMed. https://dailymed.nlm.nih.gov/dailymed/index.cfm.

Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. & Morishima, K. KEGG: new perspectives on genomes, pathways, diseases and drugs. PubMed DOI PMC

Wan, M. et al. TnT-LLM: Text mining at scale with large language models.

Thirunavukarasu, A. J. et al. Large language models in medicine. PubMed DOI

Clusmann, J. et al. The future landscape of large language models in medicine. PubMed DOI PMC

Prakash, C., Shaffer, C. L. & Nedderman, A. Analytical strategies for identifying drug metabolites. PubMed DOI

Meyer, C., Stravs, M. A. & Hollender, J. How wastewater reflects human metabolism─suspect screening of pharmaceutical metabolites in wastewater influent. PubMed DOI PMC

Wang, M. et al. Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking. PubMed DOI PMC

Brungs, C. et al. MS PubMed PMC

Kim, S. et al. PubChem 2023 update. PubMed DOI PMC

Corsello, S. M. et al. The Drug Repurposing Hub: a next-generation drug library and information resource. PubMed DOI PMC

Zdrazil, B. et al. The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. PubMed DOI PMC

Nahler, G. Anatomical therapeutic chemical classification system (ATC). In

Ross, D. H., Seguin, R. P., Krinsky, A. M. & Xu, L. High-throughput measurement and machine learning-based prediction of collision cross sections for drugs and drug metabolites. PubMed DOI PMC

Quinn, R. A. et al. Molecular networking as a drug discovery, drug metabolism, and precision medicine strategy. PubMed DOI

Chen, L. et al. Metabolite discovery through global annotation of untargeted metabolomics data. PubMed DOI PMC

Yu, N. et al. Nontarget discovery of antimicrobial transformation products in wastewater based on molecular networks. PubMed DOI

Bittremieux, W. et al. Open access repository-scale propagated nearest neighbor suspect spectral library for untargeted metabolomics. PubMed DOI PMC

Wang, M. et al. Mass spectrometry searches using MASST. PubMed DOI PMC

Mongia, M. et al. Fast mass spectrometry search and clustering of untargeted metabolomics data. PubMed

El Abiead, Y. et al. Enabling pan-repository reanalysis for big data science of public metabolomics data. PubMed DOI PMC

Creasy, D. M. & Cottrell, J. S. Unimod: Protein modifications for mass spectrometry. PubMed DOI

Kolodnitsky, A. S., Ionov, N. S., Rudik, A. V., Filimonov, D. A. & Poroikov, V. V. HGMMX: Host Gut Microbiota Metabolism Xenobiotics Database. PubMed DOI

Keller, B. O., Sui, J., Young, A. B. & Whittal, R. M. Interferences and contaminants encountered in modern mass spectrometry. PubMed DOI

Giera, M., Aisporna, A., Uritboonthai, W. & Siuzdak, G. The hidden impact of in-source fragmentation in metabolic and chemical mass spectrometry data interpretation. PubMed DOI PMC

El Abiead, Y. et al. Discovery of metabolites prevails amid in-source fragmentation. PubMed DOI

Shahneh, M. R. Z. et al. ModiFinder: Tandem mass spectral alignment enables structural modification site localization. PubMed PMC

Wishart, D. S. et al. ChemFOnt: the chemical functional ontology resource. PubMed DOI PMC

Panitchpakdi, M. et al. Non-invasive skin sampling detects systemically administered drugs in humans. PubMed DOI PMC

Scavone, J. M., Greenblatt, D. J., Harmatz, J. S., Engelhardt, N. & Shader, R. I. Pharmacokinetics and pharmacodynamics of diphenhydramine 25 mg in young and elderly volunteers. PubMed DOI

Jarmusch, A. K. et al. Enhanced characterization of drug metabolism and the influence of the intestinal microbiome: A pharmacokinetic, microbiome, and untargeted metabolomics study. PubMed DOI PMC

Jarmusch, A. K. et al. ReDU: a framework to find and reanalyze public mass spectrometry data. PubMed DOI PMC

McDonald, D. et al. American Gut: an open platform for citizen science microbiome research. PubMed DOI PMC

Audi, S. et al. The ‘top 100’ drugs and classes in England: an updated ‘starter formulary’ for trainee prescribers. PubMed DOI PMC

Fuentes, A. V., Pineda, M. D. & Venkata, K. C. N. Comprehension of top 200 prescribed drugs in the US as a resource for pharmacy teaching, training and practice. PubMed PMC

Wylie, C. E., Daniels, B., Brett, J., Pearson, S.-A. & Buckley, N. A. A national study on prescribed medicine use in Australia on a typical day. PubMed DOI

National Center for Health Statistics, Prescription Drug Use Among Adults Aged 40-79 in the United States and Canada. https://www.cdc.gov/nchs/products/databriefs/db347.htm (2019).

Helms, P. J., Ekins Daukes, S., Taylor, M. W., Simpson, C. R. & McLay, J. S. Utility of routinely acquired primary care data for paediatric disease epidemiology and pharmacoepidemiology. PubMed DOI PMC

Isacson, D. & Bingefors, K. Epidemiology of analgesic use: a gender perspective. PubMed DOI

Anthony, M. et al. Gender and age differences in medications dispensed from a national chain drugstore. PubMed DOI

Sumner, L. W. et al. Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). PubMed DOI PMC

Winston, A. & Spudich, S. Cognitive disorders in people living with HIV. PubMed DOI

Arseniou, S., Arvaniti, A. & Samakouri, M. HIV infection and depression. PubMed DOI

Donati, K., de, G., Rabagliati, R., Iacoviello, L. & Cauda, R. HIV infection, HAART, and endothelial adhesion molecules: current perspectives. PubMed DOI

Heaton, R. K. et al. Twelve-year neurocognitive decline in HIV is associated with comorbidities, not age: a CHARTER study. PubMed DOI PMC

Schmid, R. et al. Ion identity molecular networking for mass spectrometry-based metabolomics in the GNPS environment. PubMed DOI PMC

Cheng, A. G. et al. Design, construction, and in vivo augmentation of a complex gut microbiome. PubMed DOI PMC

Olbe, L., Carlsson, E. & Lindberg, P. A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole. PubMed DOI

Boix, C., Ibáñez, M., Sancho, J. V., Niessen, W. M. A. & Hernández, F. Investigating the presence of omeprazole in waters by liquid chromatography coupled to low and high resolution mass spectrometry: degradation experiments. PubMed DOI

Mathew, M., Gupta, V. D. & Bailey, R. E. Stability of omeprazole solutions at various ph values as determined by high-performance liquid chromatography. DOI

Gentry, E. C. et al. Reverse metabolomics for the discovery of chemical structures from humans. PubMed DOI PMC

Chang, F.-Y. et al. Gut-inhabiting Clostridia build human GPCR ligands by conjugating neurotransmitters with diet- and human-derived fatty acids. PubMed DOI

Mann, A. et al. Palmitoyl serine: An endogenous neuroprotective endocannabinoid-like entity after traumatic brain injury. PubMed DOI

Grevengoed, T. J. et al. PubMed DOI PMC

Waluk, D. P., Vielfort, K., Derakhshan, S., Aro, H. & Hunt, M. C. PubMed DOI

Aichler, M. et al. PubMed DOI

Mannochio-Russo, H. et al. The microbiome diversifies long- to short-chain fatty acid-derived PubMed DOI PMC

Inciarte, A. et al. Post-exposure prophylaxis for HIV infection in sexual assault victims. PubMed DOI PMC

Kamitani, E. et al. Growth in proportion and disparities of HIV PrEP use among key populations identified in the United States national goals: systematic review and meta-analysis of published surveys. PubMed DOI PMC

Walmsley, S. L. et al. Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection. PubMed DOI

Clotet, B. et al. Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials. PubMed DOI

Huhn, G. D. et al. Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in a rapid-initiation model of care for human immunodeficiency virus type 1 infection: Primary analysis of the DIAMOND study. PubMed DOI PMC

Wohl, D. A. et al. Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial. PubMed DOI

West, K. A., Schmid, R., Gauglitz, J. M., Wang, M. & Dorrestein, P. C. foodMASST a mass spectrometry search tool for foods and beverages. PubMed DOI PMC

Bento, A. P. et al. An open source chemical structure curation pipeline using RDKit. PubMed DOI PMC

Zuffa, S. et al. microbeMASST: a taxonomically informed mass spectrometry search tool for microbial metabolomics data. PubMed DOI PMC

Bittremieux, W. et al. Universal MS/MS visualization and retrieval with the metabolomics spectrum resolver web service. Preprint at 10.1101/2020.05.09.086066 (2020).

Bittremieux, W., Laukens, K., Noble, W. S. & Dorrestein, P. C. Large-scale tandem mass spectrum clustering using fast nearest neighbor searching. PubMed PMC

Schmid, R. et al. Integrative analysis of multimodal mass spectrometry data in MZmine 3. PubMed PMC

Nothias, L.-F. et al. Feature-based molecular networking in the GNPS analysis environment. PubMed DOI PMC

McDonald, D. et al. Extreme Dysbiosis of the Microbiome in Critical Illness. PubMed DOI PMC

Brennan, C. et al. Clearing the plate: a strategic approach to mitigate well-to-well contamination in large-scale microbiome studies. PubMed PMC

Chambers, M. C. et al. A cross-platform toolkit for mass spectrometry and proteomics. PubMed DOI PMC

Zhao, H. N., Kvitne, K., Brungs, C., & Dorrestein, P. GNPS Drug Library spectral files and metadata [Data set]. Zenodo. 10.5281/zenodo.17232042 (2025).

Zhao, H. N. ninahaoqizhao/Manuscript_GNPS_Drug_Library: v1.0. Zenodo. 10.5281/zenodo.17232336 (2025).

Kvitne, K. E. kinekvitne/manuscript_drug_library: v1.0.0. Zenodo. 10.5281/zenodo.17230320 (2025).

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...